Ajanta Pharma Ltd Quarterly Results

Gross Sales

1,146.13

1,186.64

1,144.92

1,054.08

1,105.15

Excise Duty

0

0

0

0

0

Net Sales

1,146.13

1,186.64

1,144.92

1,054.08

1,105.15

Other Operating Income

0

0

0

0

0

Other Income

30.44

19.48

26.47

35.5

13.59

Total Income

1,176.57

1,206.12

1,171.39

1,089.58

1,118.74

Total Expenditure

825.3

875.47

814.57

775.76

791.08

PBIDT

351.27

330.65

356.82

313.82

327.66

Interest

7.91

6.02

0.73

1.53

2.49

PBDT

343.36

324.63

356.09

312.29

325.17

Depreciation

35.97

34.39

33.97

34.25

34.26

Minority Interest Before NP

0

0

0

0

0

Tax

94.85

76.11

79.38

73.11

91.31

Deferred Tax

-20.34

-2.35

-3.03

2.21

-10.43

Reported Profit After Tax

232.88

216.48

245.77

202.72

210.03

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

232.88

216.48

245.77

202.72

210.03

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

232.88

216.48

245.77

202.72

210.03

EPS (Unit Curr.)

18.6

17.27

19.54

16.1

16.68

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

1,400

0

0

1,300

Equity

25.07

25.07

25.07

25.27

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

30.64

27.86

31.16

29.77

29.64

PBDTM(%)

29.95

27.35

31.1

29.62

29.42

PATM(%)

20.31

18.24

21.46

19.23

19